Nuveen Asset Management, LLC Johnson & Johnson Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 9,276,775 shares of JNJ stock, worth $1.36 Billion. This represents 0.45% of its overall portfolio holdings.

Number of Shares

9,276,775

Previous 9,419,745 1.52%

Holding current value

$1.36 Billion

Previous $1.48 Billion 0.61%

% of portfolio

0.45%

Previous 0.48%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$155.22 - $162.74 $22.2 Million - $23.3 Million	-142,970 Reduced 1.52%	9,276,775 $1.47 Billion
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $2.2 Million - $2.41 Million	-15,143 Reduced 0.16%	9,419,745 $1.48 Billion
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $195 Million - $218 Million	-1,251,625 Reduced 11.71%	9,434,888 $1.47 Billion
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $31.1 Million - $33.5 Million	-201,794 Reduced 1.85%	10,686,513 $1.77 Billion
Q1 2023 May 15, 2023	SELL	$151.05 - $180.26 $4.78 Million - $5.7 Million	-31,613 Reduced 0.29%	10,888,307 $1.69 Billion

Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $127 Million - $143 Million	-794,610 Reduced 6.78%	10,919,920 $1.93 Billion
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $107 Million - $119 Million	-661,110 Reduced 5.34%	11,714,530 $1.91 Billion
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $50.2 Million - $55.5 Million	298,259 Added 2.47%	12,375,640 $2.2 Billion
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $198 Million - $225 Million	1,253,500 Added 11.58%	12,077,381 $2.12 Billion
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $106 Million - $118 Million	-681,398 Reduced 5.92%	10,823,881 $1.85 Billion
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $372 Million - $413 Million	-2,303,606 Reduced 16.68%	11,505,279 $1.86 Billion
Q2 2021 Aug 16, 2021	SELL	$159.48 - $171.07 $93.6 Million - $100 Million	-586,665 Reduced 4.08%	13,808,885 $2.27 Billion
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $18.3 Million - $20.4 Million	119,687 Added 0.84%	14,395,550 $2.37 Billion
Q4 2020 May 17, 2021	BUY	$137.11 - $157.38 $1.87 Million - $2.14 Million	13,621 Added 0.1%	14,275,863 $2.25 Billion
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $7.94 Million - $9.11 Million	-57,874 Reduced 0.4%	14,262,242 $2.24 Billion
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $143 Million - $157 Million	-1,020,095 Reduced 6.65%	14,320,116 $2.13 Billion
Q2 2020 Aug 14, 2020	SELL	$128.81 - $155.51 $58.4 Million - $70.5 Million	-453,360 Reduced 2.87%	15,340,211 $2.16 Billion
Q1 2020 May 14, 2020	SELL	$111.14 - $153.99 $51.4 Million - $71.2 Million	-462,644 Reduced 2.85%	15,793,571 $2.07 Billion
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $99 Million - $114 Million	-776,818 Reduced 4.56%	16,256,215 $2.37 Billion
Q3 2019 Nov 14, 2019	BUY	$126.95 - $142.14 $13.8 Million - $15.4 Million	108,377 Added 0.64%	17,033,033 $2.2 Billion
Q2 2019 Aug 15, 2019	BUY	$131.15 - $144.24 $2.18 Billion - $2.4 Billion	16,619,550 Added 5447.14%	16,924,656 $2.36 Billion
Q1 2019 May 14, 2019	SELL	$125.72 - $139.79 $1.76 Million - $1.96 Million	-13,989 Reduced 4.38%	305,106 $42.7 Million
Q4 2018 Feb 14, 2019	BUY	$122.84 - $147.84 $1.75 Million - $2.1 Million	14,235 Added 4.67%	319,095 $41.2 Million
Q3 2018 Nov 13, 2018	BUY	$121.58 - $142.88 $824,920 - $969,440	6,785 Added 2.28%	304,860 $42.1 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $2.66 Million - $2.94 Million	-22,281 Reduced 6.96%	298,075 $36.2 Million
Q1 2018 May 14, 2018	SELL	$125.1 - $148.14 $1.38 Million - $1.63 Million	-11,028 Reduced 3.33%	320,356 $41.1 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $462,681 - $506,404	-3,526 Reduced 1.05%	331,384 $0
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $43.4 Million - $45.3 Million	334,910	334,910 $43.5 Million

Others Institutions Holding JNJ

# of Institutions

4,145

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $382B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Johnson & Johnson Transaction History